| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/23/2013 | US8491893 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 07/23/2013 | US8491890 Methods and compositions for inhibiting diseases of the central nervous system |
| 07/23/2013 | US8491886 Viruses for the treatment of cellular proliferative disorders |
| 07/23/2013 | US8491880 Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates |
| 07/23/2013 | CA2720332C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 07/23/2013 | CA2567814C Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 07/23/2013 | CA2539068C Hiv vaccines based on env of multiple clades of hiv |
| 07/23/2013 | CA2517439C Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 07/23/2013 | CA2496005C Use of botulinum toxin for the treatment of fine wrinkles and pore size |
| 07/23/2013 | CA2471968C Immunostimulatory nucleic acids and use thereof |
| 07/23/2013 | CA2332963C Combination meningitidis b/c vaccines |
| 07/23/2013 | CA2321106C Group b streptococcus antigens |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/19/2013 | WO2012097313A2 Therapeutic antibodies against ror-1 protein and methods for use of same |
| 07/19/2013 | CA2858350A1 Therapeutic antibodies against ror-1 protein and methods for use of same |
| 07/18/2013 | WO2013106852A1 Controlled delivery of tlr agonists in structural polymeric devices |
| 07/18/2013 | WO2013106834A2 Immunogenic wt-1 peptides and methods of use thereof |
| 07/18/2013 | WO2013106765A1 Biological markers for identifying patients for treatment with vegf antagonists |
| 07/18/2013 | WO2013106586A2 Anti-hla class-ib antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (ivig) useful as therapeutic ivig mimetics and methods of their use |
| 07/18/2013 | WO2013106577A2 Enhancement of transport of therapeutic molecules across the blood brain barrier |
| 07/18/2013 | WO2013106558A1 Lipid based adjuvants for dna - plasmid vaccines |
| 07/18/2013 | WO2013106548A1 Methods and cells for the production of viral vaccines |
| 07/18/2013 | WO2013106525A1 Immunogenic hpv l2-containing vlps and related compositions and methods |
| 07/18/2013 | WO2013106485A2 Ultralong complementarity determining regions and uses thereof |
| 07/18/2013 | WO2013105896A1 Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3 |
| 07/18/2013 | WO2013105105A2 Novel viral vaccine compositions and methods for preparing such vaccines |
| 07/18/2013 | WO2013104943A1 Mtb-c vaccine against asthma |
| 07/18/2013 | WO2013104873A1 Vaccine composition including hybrid nanoparticles of aluminum and a water-soluble copolymer |
| 07/18/2013 | WO2013104688A1 Cyclon expression for the identification and control of cancer cells |
| 07/18/2013 | WO2013104550A1 Kit for producing a vaccine |
| 07/18/2013 | WO2013104050A2 Method for treating breast cancer |
| 07/18/2013 | WO2013071068A3 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
| 07/18/2013 | WO2013050048A3 Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses |
| 07/18/2013 | WO2013042053A3 Compounds for use in the treatment of alzheimer's disease |
| 07/18/2013 | WO2013040517A3 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH |
| 07/18/2013 | WO2013033092A3 Streptococcus suis pilus antigens |
| 07/18/2013 | WO2013020074A3 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| 07/18/2013 | WO2012067866A8 Multivalent vaccine for filariasis |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130183741 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells |
| 07/18/2013 | US20130183386 Process for obtaining a rabbit skin comprising biological active substances |
| 07/18/2013 | US20130183378 CD133 Epitopes |
| 07/18/2013 | US20130183376 Hepatitis c virus liposome vaccine |
| 07/18/2013 | US20130183355 Delivery of self-replicating rna using biodegradable polymer particles |
| 07/18/2013 | US20130183350 Immunogenic compositions |
| 07/18/2013 | US20130183344 Recombinant vaccine against clostridium perfringens infection and epsilon toxin intoxication |
| 07/18/2013 | US20130183343 System and Method of Preparing and Storing Activated Mature Dendritic Cells |
| 07/18/2013 | US20130183341 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 07/18/2013 | US20130183340 Intradermal influenza vaccine |
| 07/18/2013 | US20130183339 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 07/18/2013 | US20130183338 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
| 07/18/2013 | US20130183336 Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology |
| 07/18/2013 | US20130183335 Recombinant modified vaccinia virus ankara influenza vaccine |
| 07/18/2013 | US20130183334 Lentiviral vectors and methods of use thereof |
| 07/18/2013 | US20130183333 Induced activation in dendritic cells |
| 07/18/2013 | US20130183332 Treatment and Prevention of Malaria |
| 07/18/2013 | US20130183330 Recombinant avian infectious coryza vaccine and process for preparing same |
| 07/18/2013 | US20130183329 Interferon-Inducing Porcine Reproductive and Respiratory Syndrome Virus Isolate |
| 07/18/2013 | US20130183328 Cancer vaccines and vaccination methods |
| 07/18/2013 | US20130183326 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 07/18/2013 | US20130183325 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/18/2013 | US20130183324 Immunogens for treatment of neoplastic and infectious disease |
| 07/18/2013 | US20130183322 Immunosuppressive drug combination for a stable and long term engraftment |
| 07/18/2013 | US20130183321 Gitr binding molecules and uses therefor |
| 07/18/2013 | US20130183319 Fgfr4 antibodies |
| 07/18/2013 | US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 07/18/2013 | US20130183316 Agonistic antibody to cd27 |
| 07/18/2013 | US20130183315 Antibodies that bind to OX40 and their uses |
| 07/18/2013 | US20130183313 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/18/2013 | US20130183312 Modular targeted therapeutic agents and methods of making same |
| 07/18/2013 | US20130183311 Bispecific binding agents for modulating biological activity |
| 07/18/2013 | US20130183303 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 07/18/2013 | US20130183302 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 07/18/2013 | US20130183301 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 07/18/2013 | US20130183300 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183297 Method of treating cancers and a pharmaceutical composition that may be used in practicing said method |
| 07/18/2013 | US20130183296 Targeted Identification of Immunogenic Peptides |
| 07/18/2013 | US20130183295 Therapy-enhancing glucan |
| 07/18/2013 | US20130183294 Methods of using fgf19 modulators |
| 07/18/2013 | US20130183293 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue , and/or fever |
| 07/18/2013 | US20130183292 Tumor therapy with an anti-vegf antibody |
| 07/18/2013 | US20130183290 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
| 07/18/2013 | US20130183289 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 07/18/2013 | US20130183288 Non-fucosylated antibodies |
| 07/18/2013 | US20130183286 Composition and method for preventing/decreasing respiratory illness |
| 07/18/2013 | US20130183285 Methods for accelerating the healing of connective tissues injuries and disorders |
| 07/18/2013 | US20130183271 Methods and Compositions Concerning Poxviruses and Cancer |
| 07/18/2013 | US20130183264 Antagonists of IL-6 to raise albumin and/or lower crp |
| 07/18/2013 | US20130183249 Stimulus Sensitive Magnetic Nanocomposite Using Pyrene Polymer, and Contrast Medium Composition Containing the Nanocomposite |
| 07/18/2013 | US20130183245 Methods of treating cerebral amyloid angiopathy |
| 07/18/2013 | CA2857400A1 Method for treating breast cancer |
| 07/17/2013 | EP2615181A1 Cyclon expression for the identification and control of cancer cells |
| 07/17/2013 | EP2615115A2 Antigen-binding constructs |
| 07/17/2013 | EP2615114A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615113A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 07/17/2013 | EP2615104A1 Hepatitis c virus liposome vaccine |
| 07/17/2013 | EP2614839A2 Method for using BOC/CDO to modulate hedgehog signaling |
| 07/17/2013 | EP2614837A1 Anti-VEGF antibody compositions and methods |
| 07/17/2013 | EP2614836A2 High growth reassortant influenza A virus |